1–3 of 3 results for geographic atrophy of the retinal pigment epithelium
Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study
David S. Boyer, MD
Updates from the Field
2021
Episode 196: Dr. Sharon Fekrat on vitreretinal fellow education, alpha-melanocyte stimulating hormone and more
Jayanth Sridhar, MD
Member Podcasts
2019
Elamipretide, a Mitochondria-Targeted Drug for the Treatment of Vision Loss
Scott W. Cousins, MD